Premium
Left ventricular hypertrophy in chronic renal failure patients
Author(s) -
KRUM Henry,
ROGER Simon
Publication year - 2002
Publication title -
nephrology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.752
H-Index - 61
eISSN - 1440-1797
pISSN - 1320-5358
DOI - 10.1111/j.1440-1797.2002.tb00508.x
Subject(s) - medicine , left ventricular hypertrophy , cardiology , heart failure , muscle hypertrophy , chronic renal failure , disease , chronic renal disease , risk factor , renal hypertrophy , kidney disease , intensive care medicine , kidney , blood pressure , diabetic nephropathy
SUMMARY: Left ventricular hypertrophy is an important risk factor for cardiovascular disease, which is a major component of premature death among renal failure patients. Early treatment of progressive renal insufficiency has the opportunity to attempt prevention of, or reduction in, the development of LVH. Therapies specifically targeted at regression of LVH (e.g. antihypertensive regimens and epoetin‐α) may, therefore, impact favourably on future cardiovascular events. Importantly, these approaches appear complementary and should be used in unison to maximize cardiovascular risk reduction in renal failure patients.